Navigation Links
Nonagenarian researcher petitions FDA to ban trans fats
Date:9/3/2009

CHAMPAIGN, Ill. "I request to ban trans fats from the American diet."

Thus begins a 3,000-word petition to the Food and Drug Administration, the work of a man on a dogged, decades-old crusade to eradicate trans fats from food.

Fred Kummerow, a 94-year-old University of Illinois veterinary biosciences professor emeritus who still conducts research on the health effects of trans fats in the diet, filed the petition with the FDA last month. The petition is now posted on the FDA Web site, and public comments are invited. (See below for information on viewing the petition and making a comment.)

"Everybody should read my petition because it will scare the hell out of them," Kummerow said.

Trans fats contribute to the two main causes of heart disease: blood clots in the coronary arteries that can lead to sudden death from a heart attack, and atherosclerosis, the buildup of plaque in the arteries that interferes with blood flow, he said. Trans fats are also known to increase low-density lipoproteins (LDLs) in the blood and to spur inflammation, both of which contribute to heart disease.

Trans fats displace the essential fatty acids linoleic acid (omega-6) and linolenic acid (omega-3), which the body needs for a variety of functions. Kummerow's own research, published last month in the journal Atherosclerosis, found that trans fats also interfere with the function of a key enzyme essential to blood flow regulation.

An earlier study from Kummerow's lab found that pregnant sows fed a diet that included trans fats passed significant quantities of the trans fats to their offspring during nursing. The piglets' plasma levels of trans fats increased from 5 percent three days after birth to 15.3 percent at 6 weeks of age.

Kummerow believes the FDA's requirement (begun in 2006) that trans fats be included on food labels is inadequate and misleading. Anything less than one-half gram of trans fats per serving can be listed as zero grams. This means that people are getting the mistaken impression that their food is trans fat-free, he said.

Although Kummerow began publishing on trans fats in 1957, his efforts against trans fats in food began in earnest in 1968, when he urged the American Heart Association to ask the Institute of Shortening and Edible Oils to have its members decrease the amount of trans fatty acids in shortenings and margarines, replacing them with essential fatty acids.

"Even then, there was strong evidence that trans fatty acids increased plasma cholesterol levels," Kummerow said.

The food oil industry reluctantly agreed to lower the trans fatty acid content and increase essential fatty acids in its products. That change coincided with a dramatic decline in coronary heart disease mortality after 1968. Kummerow believes the decline in the dietary intake of trans fats and the increase in linoleic acid could explain at least part of the reduction in mortality due to heart disease.

To reinforce his message, Kummerow keeps in his lab a sample of human arteries that are clogged with atherosclerotic plaque. Another unfortunate characteristic of trans fats is that they cause cells to increase calcium in the blood, which builds up in and narrows the arteries, the main symptom of atherosclerosis.

Atherosclerosis makes the arteries "look like old scrub boards," Kummerow said. "They look corrugated. This corrugation builds up to the point where it will stop blood flow."

Kummerow's petition was filed Aug. 7, 2009. The FDA has 180 days to respond.

"According to American Heart Association data, nearly 2,400 Americans die of heart disease each day," Kummerow said. "This statistic shows the importance of a quick response."


'/>"/>

Contact: Diana Yates
diya@illinois.edu
217-333-5802
University of Illinois at Urbana-Champaign
Source:Eurekalert  

Related biology news :

1. UT Southwestern researchers examine mechanisms that help cancer cells proliferate
2. Marine biomedicine researchers decode structure of promising sea compound
3. Researchers report gene associated with language, speech and reading disorders
4. Bats use love songs during mating, researchers say
5. Idaho researchers win grant to explore DNA frontier
6. Case Western Reserve University researcher demonstrates that messenger RNA are lost in translation
7. UCSF researchers identify 2 key pathways in adaptive response
8. NASA researcher nets first measure of Africas coastal forests
9. Disrupting a destructive duo: U of T Mississauga researchers inhibit cancer proteins
10. Researchers boost production of biofuel that could replace gasoline
11. Researcher says microchannels could advance tissue engineering methods
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Nonagenarian researcher petitions FDA to ban trans fats
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: